To the Editor The study by Dr Primrose and colleagues1 evaluated intensive follow-up strategies in patients with colorectal cancer. This subject deserves specific attention considering that surgical resection is now possible in metastatic disease, especially when metastases are localized to the liver or lungs.
We were surprised by the 15% overall death rate of patients with Dukes A (stage I) disease at 5 years, similar to the observed results for patients with Dukes B (stage II) disease (eFigure 2 in the article). Can the authors comment on this?
Sinjari M, Zoccoli G, Codacci-Pisanelli G. Surveillance for Recurrence of Colorectal Cancer. JAMA. 2014;311(20):2127-2128. doi:10.1001/jama.2014.3398